S-1
For Patients With Colorectal Cancer Liver Metastases Who Were Not Able to Curative Surgical Resection.Focused on the Treatment Effect With the Quintuple Method
Liaoning Cancer Hospital & InstitutePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the For Patients With Colorectal Cancer Liver Metastases Who Were Not Able to Curative Surgical Resection.Focused on the Treatment Effect With the Quintuple Method cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Folic Acid Liaoning Cancer Hospital & Institute | Phase 2 | CCC |
METRONIDAZOLE Liaoning Cancer Hospital & Institute | Phase 2 | CCC |
RETINOL Liaoning Cancer Hospital & Institute | Phase 2 | CCC |
Same molecule, other indications
S-1 is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →